chatGPT(5.5paid):
Summary
This paper, “Genetic regulation of fasting-induced longevity effects”, studies whether the benefits and harms of intermittent fasting depend on sex and genetic background. The authors used 800 mice, split equally by sex, across 10 Collaborative Cross inbred strains, and compared normal ad libitum feeding with 2 days per week of fasting, beginning at 6 months of age and continuing for life. They measured lifespan plus extensive longitudinal metabolic, body composition, hematologic, immune, frailty, temperature and glucose traits.
The main finding is that intermittent fasting was not uniformly beneficial. Across the 10 strains, fasting produced a modest lifespan extension in males, but not in females. In males the median lifespan benefit was about 1.7 months, and restricted mean survival time analysis estimated about 2.0 months of benefit. There was no convincing extension of maximum lifespan.
The response also differed strongly by genotype. Some female strains appeared to benefit, while others appeared to do worse. In males, most strains moved in the beneficial direction, but only a few strain-specific comparisons reached statistical significance. The authors report a significant gene-by-treatment / strain-by-sex-by-diet interaction, meaning that the same fasting protocol had different effects depending on genetic background and sex.
Physiologically, fasting changed body weight and body composition, but not always in a clearly healthy direction. It reduced body mass and, importantly, reduced lean mass in both sexes at midlife and later life, without a significant reduction in adiposity in the Collaborative Cross mice. Some strains lost lean mass despite little change in total mass, showing why body composition matters more than weight alone.
The fasting protocol also produced hematologic changes. Red cell distribution width rose in fasting mice, while mean corpuscular volume did not change substantially. The authors interpret this as compatible with erythropoietic stress or early/mixed anaemia-like effects. In females at 10 months there were reductions in haemoglobin and red blood cell count, and both sexes showed increased reticulocytes at 10 months.
Immune effects were complex and sex-specific. Some lymphoid and myeloid immune subsets changed with fasting, including B cells, CD4 T cells, NK cells, eosinophils, neutrophils and monocytes, but the genetic modulation of many immune traits was weaker than for body weight and haematology.
The paper also compares these inbred Collaborative Cross mice with a related study in Diversity Outbred mice. Despite similar genetic founder origins and similar husbandry, female outbred mice showed a significant lifespan response to 2-day intermittent fasting, whereas female inbred Collaborative Cross mice did not. This suggests that inbreeding, genetic architecture, or population structure can materially affect conclusions about dietary interventions.
Novelty
The main novelty is not simply that fasting can extend lifespan. That is already well studied. The novelty is that the authors test fasting in a genetically diverse, reproducible inbred panel and show that fasting responses are genetically conditional.
Key novel contributions are:
-
A lifespan-scale intermittent fasting study across multiple Collaborative Cross strains, rather than a single mouse strain such as C57BL/6.
-
Direct evidence that fasting response is sex-specific and genotype-specific, with males showing a modest average lifespan benefit and females showing no overall benefit in the CC panel.
-
Integration of longevity with longitudinal multisystem phenotyping, including body composition, frailty, blood indices, immune cell composition and temperature.
-
Comparison of inbred CC mice with Diversity Outbred mice, showing that even genetically related mouse resources can give different fasting-longevity results.
-
Evidence that apparent health-marker changes are not necessarily aligned with lifespan extension. For example, fasting altered body weight and immune/haematologic measures, but these changes did not straightforwardly predict longer life.
Critique
This is a strong paper in design and scale. Its biggest strength is that it challenges the common assumption that a dietary intervention has a single general effect. The data support a more realistic view: intermittent fasting is an interaction between diet, sex, genotype and age.
However, the lifespan effect is modest. In males, the median gain is only about 1.7 months, with no substantial maximum lifespan extension. That makes the result more consistent with a modest survival-shift or health-risk modification than with a strong anti-aging intervention.
A second issue is power at the strain-specific level. The total study is large, but once divided by sex, strain and diet, each subgroup is much smaller. The authors themselves note that the study was powered for global strain effects, not pairwise strain-specific differences, and that exploratory within-strain analyses should be treated as preliminary. This matters because the most interesting claim is genotype-specific benefit or harm.
A third concern is that the fasting protocol may involve nutritional stress, not just beneficial metabolic switching. The lean-mass loss and RDW changes raise the possibility that at least some effects reflect energetic or micronutrient stress. That is especially important for translation to humans, older individuals, or people at risk of sarcopenia, anaemia, frailty or kidney disease.
A fourth limitation is that the intervention is a specific and fairly severe mouse protocol: 48 hours of fasting every week. In a mouse, two days is a substantial fasting exposure because of their high metabolic rate. It should not be equated directly with common human intermittent fasting schedules such as time-restricted eating or occasional fasting.
A fifth issue is mechanistic depth. The paper is excellent phenotypically, but it does not identify the causal loci, pathways, or molecular mechanisms that explain why particular strains benefit or do worse. It shows that genetics matters, but not yet exactly which genes or pathways drive the different responses.
Finally, the comparison between Collaborative Cross and Diversity Outbred mice is valuable, but it also complicates interpretation. The female DO mice benefited from fasting whereas female CC mice did not. That may reflect inbreeding effects, genetic architecture, sampling of strains, survival differences, or other population-level differences. The comparison is informative, but not a clean mechanistic explanation.
Bottom line
The paper’s central message is important: intermittent fasting should not be treated as a universally beneficial longevity intervention. In this mouse study, benefit depended on sex and genetic background, was modest even where present, and came with potentially adverse physiological signals such as lean-mass loss and haematologic stress. Its translational implication is that fasting interventions may need to be personalised and monitored, especially in older or medically vulnerable populations.